M&A and Private Equity Practice Tops 2023 Year-End League Tables
Latham’s #1 rankings reinforce firm’s position as a global transactional powerhouse.
Latham offers life sciences and healthcare industry leaders deep sector knowledge, legal expertise, and commercial and government insight to meet client needs.
Latham’s cross-disciplinary healthcare and life sciences team delivers insightful, practical guidance and sophisticated representation to a full spectrum of companies across the globe, on every type of transaction or dispute a company may face. Many of us hold advanced scientific degrees and have served in senior positions as government regulators, C-Suite executives in leading healthcare and life sciences companies, as well as serving as primary outside counsel for key industry associations.
We regularly navigate commercial and regulatory issues related to the Food and Drug Administration, the Patent Trial and Appeals Board, the European Medicines Agency, the European Commission, and other state, and federal agencies in the US and across Europe.
We deliver:
Latham’s #1 rankings reinforce firm’s position as a global transactional powerhouse.
Firm wins top honors in six practices spanning key litigation, regulatory, and transactional areas.
Financial Times recognizes the firm’s strengths across metrics that assess legal industry leadership and strategic growth.